PATENT CLAIM ANALYSIS

Application Number: 16135729
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-03
Patent Classification: ["546", "273400"]

Abstract:
Described are N-(6-(6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-2-yl)-2,3-dihydro-1H-inden-1-yl)benzamide and acetamide-containing compounds that inhibit WDR5 and associated protein-protein interactions, pharmaceutical compositions including the compounds, and methods of using the compounds and compositions for treating disorders and conditions in a subject.

Claim (Index 12):
The compound of any of  claims 1 - 11 , or a pharmaceutically acceptable salt thereof, wherein R 3  is G 1  or -L 1 -G 2 ; G 1  is 4- to 8-membered heterocyclyl, aryl, or heteroaryl; and G 2  is aryl; wherein G 1  and G 2  are optionally substituted with 1-5 substituents independently selected from the group consisting of halogen, C 1-4 alkyl, C 1-4 haloalkyl, \u2014O\u2014C 1-4 alkyl, OH, \u2014C(O)C 1-4 alkyl, \u2014C(O)C 1-4 haloalkyl, and \u2014NHC(O)C 1-4 alkyl.

Metadata:
- Claim Count in Document: 16.0
- Percentile: 97.0
- Lexical Diversity: 1.28947
- Patent Class: 546.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15703289', '14206028', '13828285', '14392200', '13548785']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8020345078091035
- 35 USC 102 Novelty (BERT): 0.557934716205806
- Combined Prediction Score: 0.7776245286487737
- Mean Citation Score: 349.4888620000001
- Max Citation Score: 432.6185
- Similarity Product: 351.3724405166805

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test